5NX.F 5.14 (+8.21%)
FI4000506811Medical Devices & InstrumentsMedical Devices

Nexstim (5NX.F) Stock Highlights

5.14 | +8.21%
2024-10-21 05:35:50
Nexstim Oyj is a Finnish medical technology company operating in the international market. It enables the individual and effective diagnosis and treatment of challenging brain diseases. SmartFocus TMS technology is used in the NBT (Navigated Brain Therapy) equipment developed by the company, which has an FDA marketing and distribution license for the treatment of depression in the United States. NBT equipment is CE approved in Europe for use in the treatment of depression and chronic neuropathic pain. In addition, Nexstim markets NBS (Navigated Brain Stimulation) equipment based on SmartFocus TMS technology. Its NBS equipment is navigational TMS equipment for preoperative mapping of the cerebral cortex and brain speech regions.

Statistics

Range Today
5.14 5.14
Volume Today 0
Range 1 Year
1.94 4.75
Volume 1 Year 47
Range 3 Year
1.94 5.5
Volume 3 Year 92.23K
Range 10 Year
0.2796 714.759
Volume 10 Year 101.95K

Highlights

Market Capitalization 42.03M (micro)
Floating Shares 3.9M
Current Price 5.14
Price To Earnings -39.54
Price To Revenue 4.07
Price To Book 18.62
Earnings Per Share -0.13
Payout Ratio 0%

Performance

Latest +8.21%
1 Month +43.98%
3 Months +82.92%
6 Months +147.12%
1 Year +115.06%
3 Years +15.77%
5 Years +110.95%
10 Years -99.15%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.